This company listing is no longer active
PARD3 Stock Overview
Instituto Hermes Pardini S.A., together with its subsidiaries, provides medical, dental, laboratory research, clinical analysis, and supplementary diagnostic and therapeutic services in Brazil. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Instituto Hermes Pardini S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R$20.25 |
| 52 Week High | R$24.69 |
| 52 Week Low | R$16.60 |
| Beta | 0.87 |
| 1 Month Change | 0.35% |
| 3 Month Change | 1.86% |
| 1 Year Change | 15.32% |
| 3 Year Change | 4.11% |
| 5 Year Change | -19.03% |
| Change since IPO | -2.17% |
Recent News & Updates
Recent updates
Why We Like The Returns At Instituto Hermes Pardini (BVMF:PARD3)
Jul 01
What Does Instituto Hermes Pardini S.A.'s (BVMF:PARD3) Share Price Indicate?
Jun 10We Think Instituto Hermes Pardini's (BVMF:PARD3) Profit Is Only A Baseline For What They Can Achieve
Feb 17At R$22.16, Is It Time To Put Instituto Hermes Pardini S.A. (BVMF:PARD3) On Your Watch List?
Jan 31Does Instituto Hermes Pardini (BVMF:PARD3) Have A Healthy Balance Sheet?
Aug 19Is Now An Opportune Moment To Examine Instituto Hermes Pardini S.A. (BVMF:PARD3)?
Jun 08Should You Be Adding Instituto Hermes Pardini (BVMF:PARD3) To Your Watchlist Today?
May 22Here's What You Should Know About Instituto Hermes Pardini S.A.'s (BVMF:PARD3) 1.3% Dividend Yield
Apr 19The Returns On Capital At Instituto Hermes Pardini (BVMF:PARD3) Don't Inspire Confidence
Apr 02Instituto Hermes Pardini (BVMF:PARD3) Has A Pretty Healthy Balance Sheet
Mar 16Is Instituto Hermes Pardini S.A.'s (BVMF:PARD3) Recent Performance Tethered To Its Attractive Financial Prospects?
Feb 08
Would Shareholders Who Purchased Instituto Hermes Pardini's (BVMF:PARD3) Stock Three Years Be Happy With The Share price Today?
Jan 19We're Watching These Trends At Instituto Hermes Pardini (BVMF:PARD3)
Dec 28We Think Instituto Hermes Pardini (BVMF:PARD3) Can Stay On Top Of Its Debt
Dec 10Instituto Hermes Pardini S.A. Just Beat Revenue By 6.5%: Here's What Analysts Think Will Happen Next
Nov 21Our Take On The Returns On Capital At Instituto Hermes Pardini (BVMF:PARD3)
Sep 12Does Instituto Hermes Pardini (BVMF:PARD3) Have A Healthy Balance Sheet?
Aug 25Investor Optimism Abounds Instituto Hermes Pardini S.A. (BVMF:PARD3) But Growth Is Lacking
Aug 07At R$28.99, Is It Time To Put Instituto Hermes Pardini S.A. (BVMF:PARD3) On Your Watch List?
Aug 06New Forecasts: Here's What Analysts Think The Future Holds For Instituto Hermes Pardini S.A. (BVMF:PARD3)
Jul 24Is Now The Time To Put Instituto Hermes Pardini (BVMF:PARD3) On Your Watchlist?
Jul 12Instituto Hermes Pardini S.A. (BVMF:PARD3) Vies For A Place In Your Dividend Portfolio: Here's Why
Jun 29Shareholder Returns
| PARD3 | BR Healthcare | BR Market | |
|---|---|---|---|
| 7D | 2.3% | -0.8% | -1.3% |
| 1Y | 15.3% | -12.4% | -4.8% |
Return vs Industry: PARD3 exceeded the BR Healthcare industry which returned -44.6% over the past year.
Return vs Market: PARD3 exceeded the BR Market which returned -13.1% over the past year.
Price Volatility
| PARD3 volatility | |
|---|---|
| PARD3 Average Weekly Movement | 4.2% |
| Healthcare Industry Average Movement | 7.1% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in BR Market | 9.4% |
| 10% least volatile stocks in BR Market | 2.7% |
Stable Share Price: PARD3 has not had significant price volatility in the past 3 months.
Volatility Over Time: PARD3's weekly volatility (4%) has been stable over the past year.
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1959 | 7,500 | Roberto Meirelles | www.hermespardini.com.br |
Instituto Hermes Pardini S.A., together with its subsidiaries, provides medical, dental, laboratory research, clinical analysis, and supplementary diagnostic and therapeutic services in Brazil. The company offers precision medicine, medical imaging, and unprecedented differentials in the field of forensic toxicology, occupational medicine, and clinical medicine, as well as sample collection services for clinical analysis tests, imaging tests, and vaccines. In addition, it engages in the resale of laboratory test supplies; personalized medicine diagnosis; and pathological anatomy business.
Instituto Hermes Pardini S.A. Fundamentals Summary
| PARD3 fundamental statistics | |
|---|---|
| Market cap | R$2.57b |
| Earnings (TTM) | R$172.67m |
| Revenue (TTM) | R$2.10b |
14.9x
P/E Ratio1.2x
P/S RatioIs PARD3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PARD3 income statement (TTM) | |
|---|---|
| Revenue | R$2.10b |
| Cost of Revenue | R$1.53b |
| Gross Profit | R$571.04m |
| Other Expenses | R$398.37m |
| Earnings | R$172.67m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.36 |
| Gross Margin | 27.21% |
| Net Profit Margin | 8.23% |
| Debt/Equity Ratio | 53.3% |
How did PARD3 perform over the long term?
See historical performance and comparisonDividends
2.9%
Current Dividend Yield4%
Payout RatioDoes PARD3 pay a reliable dividends?
See PARD3 dividend history and benchmarks| Instituto Hermes Pardini dividend dates | |
|---|---|
| Ex Dividend Date | May 02 2023 |
| Dividend Pay Date | May 30 2023 |
| Days until Ex dividend | 701 days |
| Days until Dividend pay date | 673 days |
Does PARD3 pay a reliable dividends?
See PARD3 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/04/29 21:12 |
| End of Day Share Price | 2023/04/28 00:00 |
| Earnings | 2022/12/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Instituto Hermes Pardini S.A. is covered by 4 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pedro Mariani | BofA Global Research |
| Gustavo Miele | Goldman Sachs |
| Santhosh Seshadri | HSBC |